Persistence of Antibody Response to N. Meningitidis Group C in Children

NCT00316654 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

489

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Meningococcal Infection

Interventions

BIOLOGICAL: Meningococcal C conjugate vaccine

Sponsor

Novartis Vaccines

Collaborators

[object Object]